ArticleBritish journal of haematology2026

Safety profile of chimeric antigen receptor T-cell therapy in relapsed/refractory multiple myeloma: A systematic review and meta-analysis of proportions from clinical trials.

Charalampos Filippatos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.